Peptide Therapeutics Market Scope And Analysis

  • Report Code : TIPRE00003793
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Peptide Therapeutics Market Outlook and Scope 2031

Buy Now

Peptide Therapeutics Market Report Peptide Therapeutics Market Size and Share Peptide Therapeutics Market Scope and Analysis

Peptide Therapeutics Market Report Scope

Report Attribute Details
Market size in 2023 US$ 29.35 Billion
Market Size by 2031 US$ 73.63 Billion
Global CAGR (2023 - 2031) 11.5%
Historical Data 2021-2022
Forecast period 2023-2031
Segments Covered By Type
  • Generic
  • Innovative
By Route of Administration
  • Parenteral
  • Oral
  • Mucosal
  • Pulmonary
By Synthesis Technology
  • Solid Phase Peptide Synthesis
  • Liquid Phase Peptide Synthesis
  • Hybrid Technology
By Application
  • Cancer
  • Cardiovascular Disorder
  • Metabolic Disorder
  • Respiratory Disorder
  • Pain MAnagement
  • Dermatology
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Eli Lilly and Company
  • Amgen Inc
  • Teva Pharmaceutical Industries Ltd
  • Lonza
  • Sanofi
  • Bristol Myers Squibb Company
  • GlaxoSmithKline plc
  • AstraZeneca
  • Pfizer Inc
  • Novo Nordisk
    		•